Company

About

Bend Bioscience

Bend Bioscience

Bend, Oregon, United States

Every new drug has challenges to overcome on its journey from discovery to market. With today's more specific targets and more challenging chemical spaces, drug delivery and development often requires an enabling technology. We provide a collaborative R&D approach, specializing in particle engineering, drug delivery, drug development and manufacturing expertise to the pharmaceutical industry. We want to partner with you on your challenging molecule and help bring it to market. How can we help?

plasmidsaurus

plasmidsaurus

Eugene, Oregon, United States

We sequence whole plasmids, amplicons, whole bacterial genomes, and colonies overnight, without the need for primers and minipreps. Plasmidsaurus is on a mission to accelerate new cures and promote a healthier planet by unlocking new levels of productivity in scientists using DNA tools to bring their ideas to life. The company’s DNA sequencing services are used daily by thousands of innovators, including Nobel prize winners, dynamic biotech startups, pharmaceutical companies, research labs, and DIY biohackers. Plasmidsaurus’s global network of labs operates day and night to enable world-changing discoveries.

Serán BioScience

Serán BioScience

63040 Lower Meadow Dr, Suite 110, Bend, Oregon 97701, US

At Serán, Our mission is to provide optimized drug development and manufacturing services for our clients, from discovery to the clinic. Our science-driven approach utilizes predictive design tools, novel chemistry, analytical tools, enabling delivery technologies, and a thorough knowledge of quality and regulatory requirements to guide our customers on their clinical development path. Serán's team are experts in delivery of poorly soluble compounds. Serán employs a range of novel technologies and pharmaceutical manufacturing operations to overcome drug development challenges for both small and large molecules, including complex granulations, spray-dried dispersions, hot melt extrudates, IR and MR tablet technologies, multiparticulates, and engineered particles inhalation. Our custom-built spray driers enable a wide variety of particle formation, from nano-structures to micro-particulates. Our particle engineering approaches are combined with our broad expertise in solid dosage forms resulting in the optimum clinical trial materials for your drug, including suspensions, capsules, and tablets.

Sirona Dx

Sirona Dx

Portland, Oregon, United States

Sirona Dx is a technical CRO, providing advanced, high complexity, single cell, multi omics services to accelerate the pace of immunotherapy and targeted therapy development. In contrast to most CROs, we embrace leading edge technologies at an earlier stage, often assisting life science companies with product development. Bridging the silos between tools developers and biopharma means our clients access enabling technologies and expertise sooner and within a CLIA accredited, GCLP laboratory that supports pharma regulatory requirements. Our team can assist with platform selection and with the design, optimization and validation of complex multi-analyte assays. Harness breakthrough technologies to profile and integrate biology with single-cell resolution including tissue spatial context to reveal the next generation of precision biomarker signatures to accelerate therapies towards regulatory approval. Recognized as the original pioneers of spatial biology we launched the first spatial-omics CRO service in 2018 utilizing IMC technology developed by Fluidigm. Today our technology agnostic, spatial biology suite includes all of the leading multiplexed imaging platforms. Our team can develop panels of up to 40 markers to reveal the complex interplay between the immune system and the tumor/tissue microenvironment. We leverage CyTOF technology from Fluidigm to perform ultradeep immune profiling of whole blood and PBMCs with highly multiplexed assays of 40+ markers. High performance RNA extraction methodologies coupled with a comprehensive menu of high parameter IO expression profiling assays supports exploration of complex tumor immunobiology from challenging sample types. From exploratory testing and biomarker development through to clinical trials support, we partner with you every step of the way. Contact us with your specific requirements and our team will guide you to the optimal assays and platforms to support your study.

Yecuris, Inc.

Yecuris, Inc.

Portland, Oregon, US